Otsuka Pharmaceuticals is challenging a decision revoking its patent for an injectable version of antipsychotic drug Abilify.
A discrimination class action against AFL by First Nations players, umpires and officials has been given the OK to rejig its pleading, over the vehement protests of the league.
A judge hearing a suit against Lovisa has questioned whether it should proceed as a class action, but shut down a ‘pejorative remark’ by the jewellery chain’s barrister about Fair Work class actions.
The funder backing a class action against Transport NSW by residents displaced by the construction of Sydney’s WestConnex tunnel has brought proceedings seeking $1.4 million from the lead plaintiffs.
Suncorp has reached a settlement in a class action against unit AAI over add-on insurance, the insurer confirmed on Friday.
A judge has made a lump sum costs order against a Sydney barrister in his long running dispute with a solicitor over a $320,000 bill, saying for a second time that his conduct in filing reams of material over the issue of costs was unreasonable.
Munich Reinsurance has been given the OK to bring additional claims in its $696 million lawsuit, which accuses AMP of misleading or deceptive conduct over a quota share agreement.
Pharmaceutical giant Lundbeck has resolved its battle with Novartis unit Sandoz over top-selling drug Lexapro, a battle that has raged for years and across multiple courts.
A Tasmanian community group has lost its challenge to a decision approving the construction of a wharf to facilitate the transport of hundreds of 86 metre-long wind turbine blades for a controversial wind project on Robbins Island.
Defamation boutique Giles George has a “good arguable case” that it has a solicitor’s lien over costs payable by Nine in a defamation case by barrister Gina Edwards over social media cavoodle Oscar.